v1
Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group.
Identifier:nobleid.org/w1/20260515/AD76971F
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/AD76971F)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims